{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:40:44Z","timestamp":1784544044066,"version":"3.55.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>\n                    Outbreaks of SARS-CoV-2 are threatening the health care systems of several countries around the world. The initial control of SARS-CoV-2 epidemics relied on non-pharmaceutical interventions, such as social distancing, teleworking, mouth masks and contact tracing. However, as pre-symptomatic transmission remains an important driver of the epidemic, contact tracing efforts struggle to fully control SARS-CoV-2 epidemics. Therefore, in this work, we investigate to what extent the use of universal testing, i.e., an approach in which we screen the entire population, can be utilized to mitigate this epidemic. To this end, we rely on PCR test pooling of individuals that belong to the same households, to allow for a universal testing procedure that is feasible with the limited testing capacity. We evaluate two isolation strategies: on the one hand\n                    <jats:italic>pool isolation<\/jats:italic>\n                    , where we isolate all individuals that belong to a positive PCR test pool, and on the other hand\n                    <jats:italic>individual isolation<\/jats:italic>\n                    , where we determine which of the individuals that belong to the positive PCR pool are positive, through an additional testing step. We evaluate this universal testing approach in the\n                    <jats:italic>STRIDE<\/jats:italic>\n                    individual-based epidemiological model in the context of the Belgian COVID-19 epidemic. As the organisation of universal testing will be challenging, we discuss the different aspects related to sample extraction and PCR testing, to demonstrate the feasibility of universal testing when a decentralized testing approach is used. We show through simulation, that weekly universal testing is able to control the epidemic, even when many of the contact reductions are relieved. Finally, our model shows that the use of universal testing in combination with stringent contact reductions could be considered as a strategy to eradicate the virus.\n                  <\/jats:p>","DOI":"10.1371\/journal.pcbi.1008688","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T13:23:44Z","timestamp":1615296224000},"page":"e1008688","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["Assessing the feasibility and effectiveness of household-pooled universal testing to control COVID-19 epidemics"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3906-758X","authenticated-orcid":true,"given":"Pieter J. K.","family":"Libin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9210-1196","authenticated-orcid":true,"given":"Lander","family":"Willem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3036-617X","authenticated-orcid":true,"given":"Timothy","family":"Verstraeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4322-0770","authenticated-orcid":true,"given":"Andrea","family":"Torneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1635-2791","authenticated-orcid":true,"given":"Joris","family":"Vanderlocht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1881-0637","authenticated-orcid":true,"given":"Niel","family":"Hens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,3,9]]},"reference":[{"key":"pcbi.1008688.ref001","unstructured":"Organization WH, et al. Coronavirus disease (COVID-19) situation report, 162. 2020."},{"key":"pcbi.1008688.ref002","article-title":"Natural History of Asymptomatic SARS-CoV-2 Infection","author":"A Sakurai","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"21","key":"pcbi.1008688.ref003","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1056\/NEJMp2005630","article-title":"Developing Covid-19 vaccines at pandemic speed","volume":"382","author":"N Lurie","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"pcbi.1008688.ref004","doi-asserted-by":"crossref","unstructured":"Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). 2020.","DOI":"10.1038\/d41573-020-00016-0"},{"key":"pcbi.1008688.ref005","doi-asserted-by":"crossref","unstructured":"Hufsky F, Lamkiewicz K, Almeida A, Aouacheria A, Arighi C, Bateman A, et al. Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research. Briefings in Bioinformatics. 2020.","DOI":"10.1093\/bib\/bbaa232"},{"issue":"6490","key":"pcbi.1008688.ref006","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.abb4218","article-title":"The effect of human mobility and control measures on the COVID-19 epidemic in China","volume":"368","author":"MU Kraemer","year":"2020","journal-title":"Science"},{"key":"pcbi.1008688.ref007","unstructured":"BBC. Coronavirus: Spain imposes local lockdown in Galicia; 2020. https:\/\/www.bbc.com\/news\/world-europe-53299544."},{"key":"pcbi.1008688.ref008","unstructured":"Johnston J. Antwerp eases Coronavirus measures, keeps curfew; 2020. https:\/\/www.brusselstimes.com\/news\/belgium-all-news\/125083\/antwerp-announces-slight-relaxation-of-coronavirus-measures\/."},{"key":"pcbi.1008688.ref009","unstructured":"Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020."},{"key":"pcbi.1008688.ref010","doi-asserted-by":"crossref","unstructured":"Carf\u00ec A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020.","DOI":"10.1001\/jama.2020.12603"},{"key":"pcbi.1008688.ref011","doi-asserted-by":"crossref","unstructured":"Mitrani RD, Dabas N, Goldberger JJ. COVID-19 cardiac injury: implications for long-term surveillance and outcomes in survivors. Heart Rhythm. 2020.","DOI":"10.1016\/j.hrthm.2020.06.026"},{"issue":"8","key":"pcbi.1008688.ref012","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S2213-2600(20)30222-8","article-title":"Pulmonary fibrosis secondary to COVID-19: a call to arms?","volume":"8","author":"P Spagnolo","year":"2020","journal-title":"The Lancet Respiratory Medicine"},{"key":"pcbi.1008688.ref013","doi-asserted-by":"crossref","unstructured":"Hellewell J, Abbott S, Gimma A, Bosse NI, Jarvis CI, Russell TW, et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. The Lancet Global Health. 2020.","DOI":"10.1101\/2020.02.08.20021162"},{"issue":"1","key":"pcbi.1008688.ref014","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12916-020-01636-4","article-title":"A prospect on the use of antiviral drugs to control local outbreaks of COVID-19","volume":"18","author":"A Torneri","year":"2020","journal-title":"BMC Medicine"},{"key":"pcbi.1008688.ref015","doi-asserted-by":"crossref","unstructured":"Kucharski AJ, Klepac P, Conlan A, Kissler SM, Tang M, Fry H, et al. Effectiveness of isolation, testing, contact tracing and physical distancing on reducing transmission of SARS-CoV-2 in different settings. medRxiv. 2020.","DOI":"10.1101\/2020.04.23.20077024"},{"key":"pcbi.1008688.ref016","doi-asserted-by":"crossref","unstructured":"Peto J, Alwan NA, Godfrey KM, Burgess RA, Hunter DJ, Riboli E, et al. Universal weekly testing as the UK COVID-19 lockdown exit strategy. Lancet (London, England). 2020.","DOI":"10.1016\/S0140-6736(20)30936-3"},{"key":"pcbi.1008688.ref017","article-title":"Covid-19 mass testing facilities could end the epidemic rapidly","volume":"368","author":"J Peto","year":"2020","journal-title":"BMJ"},{"key":"pcbi.1008688.ref018","unstructured":"Food U, drug administration. Population-wide testing of SARS-CoV-2: country experiences and potential approaches in the EU\/EEA and the United Kingdom; 2020. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/covid-19-population-wide-testing-country-experiences.pdf."},{"key":"pcbi.1008688.ref019","first-page":"1","article-title":"Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo\u2019","author":"E Lavezzo","year":"2020","journal-title":"Nature"},{"key":"pcbi.1008688.ref020","doi-asserted-by":"crossref","unstructured":"Yelin I, Aharony N, Shaer Tamar E, Argoetti A, Messer E, Berenbaum D, et al. Evaluation of COVID-19 RT-qPCR test in multi-sample pools. Clinical Infectious Diseases. 2020.","DOI":"10.1101\/2020.03.26.20039438"},{"key":"pcbi.1008688.ref021","article-title":"The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19: an individual-based modelling study","author":"L Willem","year":"2020","journal-title":"Nature Communications"},{"key":"pcbi.1008688.ref022","unstructured":"Baert D. Overheid investeert 50 miljoen euro in eigen testmachines: 70.000 testen per dag dit najaar; 2020. https:\/\/www.vrt.be\/vrtnws\/nl\/2020\/08\/11\/overheid-investeert-50-miljoen-euro-in-eigen-testmachines-70-00\/"},{"key":"pcbi.1008688.ref023","unstructured":"Sciensano. COVID-19\u2014Epidemiologisch bulletin van 16 december 2020; 2020. https:\/\/covid-19.sciensano.be\/sites\/default\/files\/Covid19\/COVID-19_Daily."},{"issue":"52","key":"pcbi.1008688.ref024","doi-asserted-by":"crossref","first-page":"27142","DOI":"10.1073\/pnas.1911083116","article-title":"Virus\u2013virus interactions impact the population dynamics of influenza and the common cold","volume":"116","author":"S Nickbakhsh","year":"2019","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1719","key":"pcbi.1008688.ref025","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1098\/rspb.2010.2688","article-title":"Modelling the impact of local reactive school closures on critical care provision during an influenza pandemic","volume":"278","author":"T House","year":"2011","journal-title":"Proceedings of the Royal Society B: Biological Sciences"},{"issue":"1","key":"pcbi.1008688.ref026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1137\/0207001","article-title":"An application of bin-packing to multiprocessor scheduling","volume":"7","author":"EG Coffman","year":"1978","journal-title":"SIAM Journal on Computing"},{"key":"pcbi.1008688.ref027","doi-asserted-by":"crossref","unstructured":"Kuylen E, Stijven S, Broeckhove J, Willem L. Social Contact Patterns in an Individual-based Simulator for the Transmission of Infectious Diseases (Stride). In: ICCS; 2017. p. 2438\u20132442.","DOI":"10.1016\/j.procs.2017.05.086"},{"key":"pcbi.1008688.ref028","doi-asserted-by":"crossref","unstructured":"Abrams S, Wambua J, Santermans E, Willem L, Kylen E, Coletti P, et al. Modeling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories. medRxiv. 2020.","DOI":"10.1101\/2020.06.29.20142851"},{"key":"pcbi.1008688.ref029","unstructured":"Coletti P, Libin P, Petrof O, Abrams S, Faes C, Kuylen E, et al. The COVID-19 epidemic in Belgium: expected impact of lockdown relieve. medRxiv. 2020."},{"issue":"5","key":"pcbi.1008688.ref030","doi-asserted-by":"crossref","first-page":"2000062","DOI":"10.2807\/1560-7917.ES.2020.25.5.2000062","article-title":"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20\u201328 January 2020","volume":"25","author":"JA Backer","year":"2020","journal-title":"Eurosurveillance"},{"issue":"5","key":"pcbi.1008688.ref031","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41591-020-0869-5","article-title":"Temporal dynamics in viral shedding and transmissibility of COVID-19","volume":"26","author":"X He","year":"2020","journal-title":"Nature Medicine"},{"key":"pcbi.1008688.ref032","doi-asserted-by":"crossref","unstructured":"Faes C, Abrams S, Van~Beckhoven D, Meyfroidt G, Vlieghe E, Hens N. Time between Symptom Onset, Hospitalisation and Recovery or Death: a Statistical Analysis of Different Time-Delay Distributions in Belgian COVID-19 Patients. medRxiv. 2020.","DOI":"10.1101\/2020.07.18.20156307"},{"key":"pcbi.1008688.ref033","doi-asserted-by":"crossref","unstructured":"Herzog S, De~Bie J, Abrams S, Wouters I, Ekinci E, Patteet L, et al. Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium: a prospective cross-sectional study of residual samples. medRxiv. 2020.","DOI":"10.1101\/2020.06.08.20125179"},{"key":"pcbi.1008688.ref034","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus\u2013infected pneumonia","author":"Q Li","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"pcbi.1008688.ref035","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41591-020-0822-7","article-title":"Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China","volume":"26","author":"JT Wu","year":"2020","journal-title":"Nature Medicine"},{"issue":"8","key":"pcbi.1008688.ref036","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-020-0962-9","article-title":"Age-dependent effects in the transmission and control of COVID-19 epidemics","volume":"26","author":"NG Davies","year":"2020","journal-title":"Nature Medicine"},{"issue":"10","key":"pcbi.1008688.ref037","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S1473-3099(20)30457-6","article-title":"Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study","volume":"20","author":"AJ Kucharski","year":"2020","journal-title":"The Lancet Infectious Diseases"},{"issue":"10","key":"pcbi.1008688.ref038","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/s41591-020-1036-8","article-title":"Using a real-world network to model localized COVID-19 control strategies","volume":"26","author":"JA Firth","year":"2020","journal-title":"Nature medicine"},{"key":"pcbi.1008688.ref039","article-title":"Variation in false-negative rate of reverse transcriptase polymerase chain reaction\u2013based SARS-CoV-2 tests by time since exposure","author":"LM Kucirka","year":"2020","journal-title":"Annals of Internal Medicine"},{"key":"pcbi.1008688.ref040","unstructured":"Desmet L. Permanent \u2018out of office\u2019: bedrijven zien thuiswerk als blijvertje; 2020. https:\/\/www.demorgen.be\/nieuws\/permanent-out-of-office-bedrijven-zien-thuiswerk-als-blijvertje~be85fa1a\/."},{"issue":"11","key":"pcbi.1008688.ref041","doi-asserted-by":"crossref","first-page":"e48695","DOI":"10.1371\/journal.pone.0048695","article-title":"A nice day for an infection? Weather conditions and social contact patterns relevant to influenza transmission","volume":"7","author":"L Willem","year":"2012","journal-title":"PloS one"},{"key":"pcbi.1008688.ref042","article-title":"False Negative Tests for SARS-CoV-2 Infection\u2014Challenges and Implications","author":"S Woloshin","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"pcbi.1008688.ref043","doi-asserted-by":"crossref","unstructured":"Larremore DB, Wilder B, Lester E, Shehata S, Burke JM, Hay JA, et al. Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance. MedRxiv. 2020.","DOI":"10.1101\/2020.06.22.20136309"},{"key":"pcbi.1008688.ref044","unstructured":"Food U, drug administration. FDA Issues Emergency Use Authorization to Yale School of Public Health for SalivaDirect; 2020. https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-yale-school-public-health."},{"key":"pcbi.1008688.ref045","doi-asserted-by":"crossref","unstructured":"de Wolff T, Pfl\u00fcger D, Rehme M, Heuer J, Bittner MI. Evaluation of Pool-Based Testing Approaches to Enable Population-wide Screening for COVID-19. arXiv preprint arXiv:200411851. 2020.","DOI":"10.1371\/journal.pone.0243692"},{"key":"pcbi.1008688.ref046","doi-asserted-by":"crossref","unstructured":"Taipale J, Romer P, Linnarsson S. Population-scale testing can suppress the spread of COVID-19. medRxiv. 2020.","DOI":"10.1101\/2020.04.27.20078329"},{"key":"pcbi.1008688.ref047","doi-asserted-by":"crossref","unstructured":"Bloom JS, Jones EM, Gasperini M, Lubock NB, Sathe L, Munugala C, et al. Swab-Seq: A high-throughput platform for massively scaled up SARS-CoV-2 testing. medRxiv. 2020.","DOI":"10.1101\/2020.08.04.20167874"},{"key":"pcbi.1008688.ref048","article-title":"Fighting homelessness and housing exclusion in Europe","volume":"93","author":"I Baptista","year":"2019","journal-title":"A Study of National Policies, European Social Policy Network (ESPN)"},{"issue":"37","key":"pcbi.1008688.ref049","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1016\/j.vaccine.2019.06.081","article-title":"Defining hard-to-reach populations for vaccination","volume":"37","author":"S Ozawa","year":"2019","journal-title":"Vaccine"},{"key":"pcbi.1008688.ref050","unstructured":"Pavelka M, van Zandvoort K, Abbott S, Sherratt K, Majdan M, Jarcuska P, et al. The effectiveness of population-wide, rapid antigen test based screening in reducing SARS-CoV-2 infection prevalence in Slovakia. medRxiv. 2020."},{"issue":"10260","key":"pcbi.1008688.ref051","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0140-6736(20)32261-3","article-title":"Slovakia to test all adults for SARS-CoV-2","volume":"396","author":"E Holt","year":"2020","journal-title":"The Lancet"},{"key":"pcbi.1008688.ref052","doi-asserted-by":"crossref","first-page":"eabd3083","DOI":"10.1126\/sciadv.abd3083","article-title":"Low-cost measurement of facemask efficacy for filtering expelled droplets during speech","author":"EP Fischer","year":"2020","journal-title":"Science Advances"},{"key":"pcbi.1008688.ref053","doi-asserted-by":"crossref","unstructured":"Cohen MS, Corey L. Combination prevention for COVID-19; 2020.","DOI":"10.1126\/science.abc5798"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008688","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T13:13:30Z","timestamp":1619615610000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008688"}},"subtitle":[],"editor":[{"given":"Alex","family":"Perkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,9]]},"references-count":53,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1008688","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.10.03.20205765","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,9]]}}}